GlassScriptPhysician profile
Eileen Holt
NPI 1629439054
$7,474.85
in general payments reported to CMS, 2019-2025
38 companies · $964 in 2025
The $964 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,616 · 2022: $1,936 · 2023: $1,675 · 2024: $1,283 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,922.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,976.61 | 2021-2025 | |
| Pfizer INC. | $467.54 | 2021-2025 | |
| Abbott Laboratories | $433.38 | 2021-2025 | Eterna, Freestyle Libre 3, Proclaim |
| Biohaven Pharmaceuticals, INC. | $379.49 | 2021 | |
| Medtronic, INC. | $339.49 | 2022-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Ibsa Pharma INC. | $282.18 | 2023-2024 | Tirosint, Licart, Tirosint |
| Biohaven Pharmaceutical Holding Company LTD. | $253.32 | 2022 | |
| Arbor Pharmaceuticals, INC. | $233.60 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $229.43 | 2021-2024 | Belbuca, Xtampza |
| Teva Pharmaceuticals USA, INC. | $219.44 | 2021-2023 | Ajovy |
| Lilly USA, LLC | $178.72 | 2021-2024 | Emgality, Reyvow |
| Nalu Medical, INC. | $176.73 | 2021-2023 | Nalu Neurostimulation System |
| Amgen INC. | $158.54 | 2021-2022 | |
| Novo Nordisk INC | $140.56 | 2025 | Ozempic, Wegovy, Rybelsus |
| Scilex Pharmaceuticals INC. | $127.33 | 2022-2023 | Ztlido |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.